Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185468 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-08-14 | 2025-11-07 | 265284 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-19 | 2025-08-22 | 260690 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-07-03 | 2025-10-24 | 261641 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260156 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-12 | 2025-08-22 | 260159 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260162 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Actual shortage | 2025-05-15 | 2026-01-15 | 257519 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260669 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260678 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-10 | 260687 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Resolved | 2025-05-15 | 2025-07-18 | 257525 |
| APO-LEVOTHYROXINE | 112MCG | TABLET | Resolved | 2025-06-19 | 2025-11-07 | 260693 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-20 | 2025-10-16 | 260817 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-31 | 260820 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-10 | 260823 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-07-10 | 2025-11-14 | 262425 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-10 | 262429 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-07-03 | 2025-10-10 | 261632 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |